Stonegate Capital Partners updated coverage on Viemed Healthcare, Inc. (NASDAQ: VMD) following the company's first quarter 2026 results, which highlighted improving growth quality beyond reported scale. The company's revenue mix is shifting, with sleep, resupply, and maternal health becoming larger contributors, thereby reducing reliance on legacy ventilation and improving capital efficiency. Ventilation appears to be transitioning through the National Coverage Determination (NCD) process, with better new-start activity and improving compliance, though turnover continues to pressure census. According to Stonegate, the broader mix is driving stronger free cash flow (FCF) conversion as these newer segments scale.
Key financial takeaways from the quarter include meaningful improvement in FCF conversion. Cash flow from operations (CFFO) increased to $8.1 million from $2.9 million in the same period last year, while trailing twelve-month (TTM) FCF rose to $36.3 million from $23.3 million at the end of fiscal 2025. The revenue mix continued to improve, with ventilator rentals declining to 46.9% of total revenue from 54.4% a year ago, and Commercial payors increasing to 23% from 17%. Sleep and resupply remain the clearest growth drivers: PAP patients increased 57% year-over-year to 35,938, new patient starts grew 42%, and resupply patients increased 47% year-over-year.
These results underscore Viemed's strategic pivot toward higher-margin, capital-efficient product lines. The expansion in sleep and resupply, along with the addition of maternal health services, is diversifying the revenue base and enhancing cash flow generation. For investors, the improved FCF conversion signals better operational efficiency and a stronger balance sheet. The full announcement, including downloadable images and bios, is available here.
Stonegate Capital Partners, a capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services, issued the update. The firm's affiliate, Stonegate Capital Markets (member FINRA), offers investment banking, equity research, and capital raising services for public and private companies.
